• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

Validation of OMICS data of urological malignancies for the clinical use

Research Project

  • PDF
Project/Area Number 18209049
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKyoto University

Principal Investigator

OGAWA Osamu  Kyoto University, 大学院・医学研究科, 教授 (90260611)

Co-Investigator(Kenkyū-buntansha) NISHIYAMA Hiroyuki  京都大学, 大学院・医学研究科, 准教授 (20324642)
INUI Kenichi  京都大学, 大学院・医学研究科, 教授 (70034030)
FUKUSHIMA Masanori  京都大学, 大学院・医学研究科, 教授 (80107820)
TUJIMOTO Gouzo  京都大学, 大学院・薬学研究科, 教授 (80172013)
NAKAMURA Eijiro  京都大学, 大学院・医学研究科, 講師 (90293878)
Project Period (FY) 2006 – 2009
Keywords泌尿器科癌 / OMICS / 遺伝子解析 / 網羅的発現解析 / プロテオーム
Research Abstract

In this project we aimed to carry out experiments which were essential for application of our achieved findings to clinical settings. First, we developed a comprehensive database incorporating genomic data including gene polymorphism, transcriptome data, and proteomic data. Second, we explored novel molecular targets for diagnosis or treatment by analyzing this database and clinical information. Finally, functions and roles of the molecules were investigated using in-vitro and in-vivo experimental models.

  • Research Products

    (21 results)

All 2010 2009 2008 2007 2006 Other

All Journal Article (19 results) (of which Peer Reviewed: 19 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.2010

    • Author(s)
      Terada N, Ogawa O, et al.
    • Journal Title

      Cancer Res (70)

      Pages: 1606-1615

    • Peer Reviewed
  • [Journal Article] Activation of Racl is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo2010

    • Author(s)
      Kobayashi T, Nakamura E, Ogawa O, et al.
    • Journal Title

      Mol Endocrinol 24(4)

      Pages: 722-34

    • Peer Reviewed
  • [Journal Article] Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells.2009

    • Author(s)
      Kobayashi T, Nakamura E, Ogawa O, et al.
    • Journal Title

      Biochem Biophys Res Commun. 387(1)

      Pages: 196-201

    • Peer Reviewed
  • [Journal Article] Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4.2009

    • Author(s)
      Nishizawa K, Nishiyama H, Ogawa O, et al.
    • Journal Title

      Int J Cancer

    • Peer Reviewed
  • [Journal Article] Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.2008

    • Author(s)
      Kawanishi H, Tsujimoto G, Nakamura E, Ogawa O, et al.
    • Journal Title

      Clin Cancer Res (14)

      Pages: 2579-2587

    • Peer Reviewed
  • [Journal Article] Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction ofinactivated glycogen synthase kinase-3beta with p53.2008

    • Author(s)
      Matsui Y, Ogawa O, Nishiyama H., et al.
    • Journal Title

      Oncogene (27)

      Pages: 4603-4614

    • Peer Reviewed
  • [Journal Article] Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.2008

    • Author(s)
      Terada N, Ogawa O, et al.
    • Journal Title

      Prostate (68)

      Pages: 1689-1695

    • Peer Reviewed
  • [Journal Article] Microarray-based identification of CUB-domain containing protein 1 as a potentialprognostic marker in conventional renal cell carcinoma2008

    • Author(s)
      Awakura Y, Nakamura E, Tsujimoto G, Ogawa, et al.
    • Journal Title

      J Cancer Res Clin Oncol (134)

      Pages: 1363-1369

    • Peer Reviewed
  • [Journal Article] Methylation-associated silencing of TU3A in human cancers.2008

    • Author(s)
      Awakura Y, Nakamura E, Ogawa O, et al.
    • Journal Title

      Int J Oncol (33)

      Pages: 893-899

    • Peer Reviewed
  • [Journal Article] Methylation-associated silencing of SFRP1 in renal cell carcinoma.2008

    • Author(s)
      Awakura Y, Nakamura E, Ogawa O, et al.
    • Journal Title

      Oncol Rep. 20(5)

      Pages: 1257-63

    • Peer Reviewed
  • [Journal Article] P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.2007

    • Author(s)
      Ito M, Nishiyama H, Ogawa O, et al.
    • Journal Title

      J Urol (178)

      Pages: 1073-1079

    • Peer Reviewed
  • [Journal Article] Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation2007

    • Author(s)
      Kawanishi H, Nishiyama H, Ogawa O, et al.
    • Journal Title

      Br J Cancer (97)

      Pages: 260-266

    • Peer Reviewed
  • [Journal Article] Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.2007

    • Author(s)
      Matsui Y, Nishiyama H, Ogawa O, at al.
    • Journal Title

      Cancer Res (67)

      Pages: 1212-1220

    • Peer Reviewed
  • [Journal Article] The roles of androgen-dependent and-independent activation of signal transduction pathways for cell proliferation of prostate cancer cells.2007

    • Author(s)
      Inoue T, Ogawa O, Nakamura E, et al.
    • Journal Title

      Expert Rev Endocrinol Metab (2)

      Pages: 689-704

    • Peer Reviewed
  • [Journal Article] STAT 3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.2007

    • Author(s)
      Ito N, Nakamura E, Ogawa O, et al.
    • Journal Title

      J Clin Oncol (25)

      Pages: 2785-2791

    • Peer Reviewed
  • [Journal Article] Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity2007

    • Author(s)
      Shang D, Nishiyama H, Ogawa O, et al.
    • Journal Title

      Eur Urol 52

      Pages: 1131-1139

    • Peer Reviewed
  • [Journal Article] Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.2007

    • Author(s)
      Shang D, Ogawa O, et al.
    • Journal Title

      Urology 69

      Pages: 1007-1012

    • Peer Reviewed
  • [Journal Article] Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von hippel-lindau tumor suppressor protein.2006

    • Author(s)
      Nakamura E, Ogawa O, et al.
    • Journal Title

      Am J Pathol 168

      Pages: 574-584

    • Peer Reviewed
  • [Journal Article] Increased Akt and phosphorylated Akt expression associated with malignant biological features of prostate cancer in Japanese men.

    • Author(s)
      Shimizu Y, Nakamura E, Ogawa O., et al.
    • Journal Title

      BJU Int

      Pages: 685-690

    • Peer Reviewed
  • [Remarks]

    • URL

      http://www.urology.kuhp.kyoto-u.ac.jp/

  • [Patent(Industrial Property Rights)] 前立腺癌のホルモン不応性獲得に関与する遺伝子および治療薬2009

    • Inventor(s)
      小川修、辻本豪三, 他
    • Industrial Property Rights Holder
      松本紘、川〓和一十
    • Industrial Property Number
      特許権2009-019701
    • Filing Date
      2009-01-30

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi